Pitavastatin in cardiometabolic disease: therapeutic profile 2013年5月30日 - A subanalysis of the J-LIT study showed that a 2.6 mmol/l (10 mg/dl) .... in Patients with Impaired Glucose Tolerance (J-PREDICT) study (n~ ...
Japan Prevention Trial of Diabetes by Pitavastatin ... - Springer 2011年10月1日 - The J-PREDICT study is a world first to evaluate the effect of a statin on the onset of diabetes as the primary endpoint and will providing useful ...
Statin diabetogenicity: guidance for clinicians 2013年5月30日 - Further studies are required to understand whether all statins have the .... Impaired Glucose Tolerance (J-PREDICT) study – is an open-label, ...
J-PREDICT - ClinicalTrials.gov 2006年3月5日 - The purpose of this study is to evaluate the effects of pitavastatin for preventing ... in Patients With Impaired Glucose Tolerance (J-PREDICT) ...
Japan Prevention Trial of Diabetes by Pitavastatin in ... Japan Prevention Trial of Diabetes by Pitavastatin in Patients with Impaired Glucose Tolerance (the J-PREDICT study): rationale, study design, and clinical ...
Pitavastatin Ameliorates Insulin Resistance in Type 2 ... 2012年12月26日 - study showed that rosuvastatin treatment was increased HbA1c and .... on glucose metabolism is clearly warranted J-PREDICT [16], a study.
Pitavastatin for the Delay or Prevention of Diabetes ... - OASIS To clarify this issue, we performed the Japan Prevention Trial of Diabetes by Pitavastatin in Patients with Impaired Glucose Tolerance (J-PREDICT) study, which ...
UMIN-CTR Clinical Trial - UMIN Clinical trials registry 2013年11月28日 - Official scientific title of the study, Japan Prevention Trial of Diabetes by Pitavastatin in Patients With Impaired Glucose Tolerance (J-PREDICT).
Statins are diabetogenic - Myth or reality? - ABC a number of studies have demonstrated the efficacy of statins in decreasing the ..... J-PREDICT study was initiated in April 2007, and 1269 individuals were ...
Statin induced diabetes and its clinical implications Aiman U ... 2014年7月5日 - In contrast, the prospective study of pravastatin in the elderly at risk, .... Hopefully, J-PREDICT results will provide useful insights about this ...
